PRM2 | Protamine 2 | | | | | | Tissue enriched |
BPIFA2 | BPI fold containing family A, member 2 | Predicted secreted proteins
| | | | | Tissue enriched |
HMGB4 | High mobility group box 4 | | | | | | Tissue enriched |
F2 | Coagulation factor II (thrombin) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CFHR2 | Complement factor H-related 2 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PGA3 | Pepsinogen 3, group I (pepsinogen A) | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
CA6 | Carbonic anhydrase VI | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
AKAP4 | A kinase (PRKA) anchor protein 4 | Cytoskeleton related proteins
| | | | | Tissue enriched |
MBL2 | Mannose-binding lectin (protein C) 2, soluble | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
TNP1 | Transition protein 1 (during histone to protamine replacement) | | | | | | Tissue enriched |
SHCBP1L | SHC SH2-domain binding protein 1-like | | | | | | Tissue enriched |
SFTPA1 | Surfactant protein A1 | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
AHSG | Alpha-2-HS-glycoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
UBQLN3 | Ubiquilin 3 | | | | | | Tissue enriched |
CYP11B1 | Cytochrome P450, family 11, subfamily B, polypeptide 1 | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins
| | | | | Tissue enriched |
ACTL7A | Actin-like 7A | Cytoskeleton related proteins
| | | | | Tissue enriched |
APOC4 | Apolipoprotein C-IV | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
KLK3 | Kallikrein-related peptidase 3 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
C4orf40 | Chromosome 4 open reading frame 40 | Predicted secreted proteins
| | | | | Tissue enriched |
TMEM174 | Transmembrane protein 174 | Predicted membrane proteins
| | | | | Tissue enriched |
GIF | Gastric intrinsic factor (vitamin B synthesis) | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
SMR3A | Submaxillary gland androgen regulated protein 3A | Predicted secreted proteins
| | | | | Tissue enriched |
SPATA3 | Spermatogenesis associated 3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC22A8 | Solute carrier family 22 (organic anion transporter), member 8 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CYP11B2 | Cytochrome P450, family 11, subfamily B, polypeptide 2 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Tissue enriched |
HDGFL1 | Hepatoma derived growth factor-like 1 | | | | | | Tissue enriched |
UMOD | Uromodulin | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
CFHR5 | Complement factor H-related 5 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
TG | Thyroglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SERPINC1 | Serpin peptidase inhibitor, clade C (antithrombin), member 1 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
MUC7 | Mucin 7, secreted | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
C2orf57 | Chromosome 2 open reading frame 57 | | | | | | Tissue enriched |
MYBPC3 | Myosin binding protein C, cardiac | Disease related genes Plasma proteins
| | | | | Tissue enriched |
ACTRT2 | Actin-related protein T2 | Cytoskeleton related proteins
| | | | | Tissue enriched |
PIP | Prolactin-induced protein | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SFTPB | Surfactant protein B | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CASP14 | Caspase 14, apoptosis-related cysteine peptidase | Enzymes Plasma proteins
| | | | | Tissue enriched |
SLC12A1 | Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
MYL7 | Myosin, light chain 7, regulatory | | | | | | Tissue enriched |
STATH | Statherin | Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
CYP2A6 | Cytochrome P450, family 2, subfamily A, polypeptide 6 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SPATA16 | Spermatogenesis associated 16 | Disease related genes
| | | | | Tissue enriched |
CSHL1 | Chorionic somatomammotropin hormone-like 1 | Predicted secreted proteins
| | | | | Tissue enriched |
CYP1A2 | Cytochrome P450, family 1, subfamily A, polypeptide 2 | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
FNDC8 | Fibronectin type III domain containing 8 | | | | | | Tissue enriched |
SYCN | Syncollin | Predicted secreted proteins
| | | | | Tissue enriched |
OPALIN | Oligodendrocytic myelin paranodal and inner loop protein | Predicted membrane proteins
| | | | | Tissue enriched |
DEFA1 | Defensin, alpha 1 | Cancer-related genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
BPIFA3 | BPI fold containing family A, member 3 | Predicted secreted proteins
| | | | | Tissue enriched |
CELA3A | Chymotrypsin-like elastase family, member 3A | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |